超快速MRI对传统DCE-MRI评估乳腺癌患者术前MRI的附加效用
本回顾性研究纳入101例乳腺癌患者的202个乳腺病灶,评估超快速MRI参数在常规DCE-MRI基础上的附加诊断价值。使用初始强化阶段(≤2期)和最大斜率(>9.8%/秒)截断值后,常规DCE-MRI评估肿块的 specificity 从29.4%显著提高至64.7%(p < 0.001),而敏感度无显著下降(100% vs 88.2%,p = 0.157)。
要点
- 超快速MRI参数(初始强化阶段、最大相对强化、斜率、最大斜率)在良恶性病灶间均有显著差异(p < 0.001)。
- 初始强化阶段和最大斜率是良恶性鉴别中差异显著且可靠性最高的两个参数。
- 联合超快速MRI截断值可显著提高常规DCE-MRI评估肿块的 specificity(29.4% vs 64.7%)。
核心结论
- 额外使用超快速MRI可提高常规DCE-MRI评估乳腺癌患者MRI检出肿块的 specificity。
研究设计与样本
- 回顾性研究纳入101例连续乳腺癌患者,共202个乳腺病灶(62个良性,140个恶性)。
- 所有患者接受术前DCE-MRI联合超快速成像(9组图像,时间分辨率6.5秒)。
- 两名阅片者使用常规DCE-MRI评估BI-RADS分类,并使用超快速MRI评估初始强化阶段、最大相对强化、斜率及动力学曲线最大斜率。
- 对97个额外MRI检出病灶,使用截断值重新评估BI-RADS分类,并比较常规DCE-MRI与常规联合超快速DCE-MRI的诊断效能。
诊断标准与关键数值
- 超快速MRI所有参数在良恶性肿瘤间差异均有统计学意义(p < 0.001)。
- 初始强化阶段(≤2期)和最大斜率(>9.8%/秒)是良恶性鉴别中差异显著且可靠性最高的两个参数。
- 使用上述截断值后,常规DCE-MRI评估肿块的 specificity 从29.4%提高至64.7%(p < 0.001)。
- 联合超快速MRI后敏感度从100%降至88.2%,但无统计学显著差异(p = 0.157)。
临床应用与阅片要点
- 在常规DCE-MRI基础上,可参考初始强化阶段≤2期和最大斜率>9.8%/秒的截断值,辅助鉴别乳腺良恶性肿块。
- 联合超快速MRI参数有助于提高MRI检出肿块的 specificity,可能减少良性病变的误判。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate whether the additional use of ultrafast MRI can improve the diagnostic performance of conventional dynamic contrast-enhanced MRI (DCE-MRI) in evaluating MRI-detected lesions in breast cancer patients.
METHODS: This retrospective study enrolled 101 consecutive breast cancer patients with 202 breast lesions (62 benign and 140 malignant) who underwent preoperative DCE-MRI with ultrafast imaging (9 image sets with 6.5-second temporal resolution). Two reviewers assessed the BI-RADS categories of breast lesions using conventional DCE-MRI and assessed the following parameters using the ultrafast MRI: initial enhancement phase, maximum relative enhancement, slope, and maximum slope (slopemax) on the kinetic curve. Interobserver agreement was analyzed between the two reviewers. The ultrafast MRI parameters were compared between benign and malignant tumors, and cut-off values were determined. For 97 additional MRI-detected lesions, the BI-RADS category was re-assessed using cut-off values, and the diagnostic performance was compared between the conventional DCE-MRI and the combined conventional and ultrafast DCE-MRI.
RESULTS: All ultrafast MRI parameters differed significantly between malignant and benign tumors (p < 0.001). Initial enhancement phase by reviewer and slopemax were the top two parameters showing significant differences between benign and malignant tumors with high reliability. With the use of cut-off values for initial enhancement phase (≤phase 2) and slopemax (>9.8%/sec), the specificity of conventional DCE-MRI was significantly increased (29.4% vs 64.7%, p < 0.001) without significant loss of sensitivity (100% vs 88.2%, p = 0.157) in evaluating masses.
CONCLUSIONS: The additional use of ultrafast MRI can improve the specificity of conventional DCE-MRI when evaluating MRI-detected masses in breast cancer patients.
引用
- Lee SJ, Ko KH, Jung HK, et al. The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients. Eur J Radiol. 2020. PMID: 31981877. doi:10.1016/j.ejrad.2020.108841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。